Literature DB >> 21620535

Synthesis, characterization and antimicrobial studies of some new pyrazole incorporated imidazole derivatives.

A M Vijesh1, Arun M Isloor, Sandeep Telkar, S K Peethambar, Sankappa Rai, Nishitha Isloor.   

Abstract

In the present study two series of novel imidazole derivatives containing substituted pyrazole moiety (3a-d and 5a-j) were synthesized. The first series were synthesized by the reaction of 3-aryl-1H-pyrazole-4-carbaldehyde thiosemicarbazones (2a-d) with DMAD and the second series by the reaction of 3-aryl-1H-pyrazole-4-carbaldehydes (1a-e) with 1,2-diketones (4a,b) in the presence of ammonium acetate. Structures of newly synthesized compounds were characterized by spectral studies. New compounds were screened for antifungal and antibacterial activities. Among the synthesized compounds, compound 3c was found to be potent antimicrobial agent. The acute oral toxicity study for the compound 3c was carried out and the experimental studies revealed that compound 3c is safe up to 3000 mg/kg and no death of animals were recorded.
Copyright © 2011. Published by Elsevier Masson SAS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21620535     DOI: 10.1016/j.ejmech.2011.05.005

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  12 in total

Review 1.  Synthesis and Pharmacological Activities of Pyrazole Derivatives: A Review.

Authors:  Khalid Karrouchi; Smaail Radi; Youssef Ramli; Jamal Taoufik; Yahia N Mabkhot; Faiz A Al-Aizari; M'hammed Ansar
Journal:  Molecules       Date:  2018-01-12       Impact factor: 4.411

2.  2-(chromon-3-yl)imidazole derivatives as potential antimicrobial agents: synthesis, biological evaluation and molecular docking studies.

Authors:  Shweta Sharma; Vishal Sharma; Gurpreet Singh; Harpreet Kaur; Shubham Srivastava; Mohan Paul S Ishar
Journal:  J Chem Biol       Date:  2016-11-16

3.  Synthesis, crystal structure, Hirshfeld surface analysis, DFT, molecular docking and molecular dynamic simulation studies of (E)-2,6-bis(4-chlorophenyl)-3-methyl-4-(2-(2,4,6-trichlorophenyl)hydrazono)piperidine derivatives.

Authors:  L Athishu Anthony; D Rajaraman; G Sundararajan; M Suresh; P Nethaji; R Jaganathan; Kumaradhas Poomani
Journal:  J Mol Struct       Date:  2022-06-08       Impact factor: 3.841

Review 4.  An Updated Review on the Synthesis and Antibacterial Activity of Molecular Hybrids and Conjugates Bearing Imidazole Moiety.

Authors:  Renzo Rossi; Maurizio Ciofalo
Journal:  Molecules       Date:  2020-11-04       Impact factor: 4.411

Review 5.  Imidazoles as potential anticancer agents.

Authors:  Imran Ali; Mohammad Nadeem Lone; Haasan Y Aboul-Enein
Journal:  Medchemcomm       Date:  2017-04-13       Impact factor: 3.597

6.  Crystal structure of (4Z)-4-[(di-methyl-amino)-methyl-idene]-3,5-dioxo-2-phenyl-pyrazolidine-1-carbaldehyde.

Authors:  Joel T Mague; Shaaban K Mohamed; Mehmet Akkurt; Eman A Ahmed; Ahmed Khodairy
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-06-03

7.  Crystal structure of 1-[2-(4-nitro-phen-yl)-4,5-diphenyl-1H-imidazol-1-yl]propan-2-ol.

Authors:  Jim Simpson; Shaaban K Mohamed; Adel A Marzouk; Antar A Abdelhamid; Mustafa R Albayati
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2017-08-30

8.  Synthesis and antimicrobial activity of some new pyrazoles, fused pyrazolo[3,4-d]-pyrimidine and 1,2-dihydroimidazo-[2,1-c][1,2,4]triazin-6-one derivatives.

Authors:  Sobhi Mohamed Gomha; Huwaida M E Hassaneen
Journal:  Molecules       Date:  2011-08-04       Impact factor: 4.411

9.  Sustainable Synthetic Approach for (Pyrazol-4-ylidene)pyridines By Metal Catalyst-Free Aerobic C(sp2)-C(sp3) Coupling Reactions between 1-Amino-2-imino-pyridines and 1-Aryl-5-pyrazolones.

Authors:  Hamada Mohamed Ibrahim; Haider Behbehani
Journal:  ACS Omega       Date:  2019-07-05

10.  Quorum sensing modulation and inhibition in biofilm forming foot ulcer pathogens by selected medicinal plants.

Authors:  Tebatso G Mashamba; Idowu J Adeosun; Itumeleng T Baloyi; Emmanuel T Tshikalange; Sekelwa Cosa
Journal:  Heliyon       Date:  2022-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.